Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1Gastrointestinal 1Breast 1

Conditions

Neoplasms 6Colorectal Neoplasms 4Lung Neoplasms 3Breast Neoplasms 3Uterine Cervical Neoplasms 2Prostatic Neoplasms 2Pain 2Motor Activity 2Hematopoietic and Lymphatic System Neoplasm 2Carcinoma, Non-Small-Cell Lung 2Breast Carcinoma In Situ 2Squamous Cell Carcinoma of Head and Neck 1Smoking Cessation 1Sedentary Behavior 1Sarcoma 1Recurrence 1Pyloric Stenosis, Hypertrophic 1Pulmonary Disease, Chronic Obstructive 1Polyps 1Papillomavirus Infections 1Ovarian Neoplasms 1Neoplasm Metastasis 1Myelodysplastic Syndromes 1Metastatic Pancreatic Adenocarcinoma 1Malignant Hepatobiliary Neoplasm 1Lymphoma, Non-Hodgkin 1Leukemia, Myeloid, Acute 1Insulin Resistance 1Hodgkin Disease 1Hereditary Breast and Ovarian Cancer Syndrome 1

Interventions

Paclitaxel 326Carboplatin 318Bevacizumab 167Gemcitabine 106pembrolizumab 100liposomal doxorubicin 100Cyclophosphamide 94Topotecan 93Cisplatin 89olaparib 86niraparib 60Docetaxel 56Taxes 52Doxorubicin 50Drug Therapy 42fludarabine 39Filgrastim 39Nivolumab 37Etoposide 32Specimen Handling 31Magnetic Resonance Spectroscopy 29Immunoglobulin G 27Disulfides 27Peripheral Blood Stem Cell Transplantation 26Albumin-Bound Paclitaxel 25durvalumab 24aldesleukin 24Hyperthermic Intraperitoneal Chemotherapy 24Oxaliplatin 23Biopsy 21

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Ovarian Neoplasms × Telemedicine × Clear all
NCT00609505 2012-02-22

Telemedicine vs. Face-to-Face Cancer Genetic Counseling

Duke University

Phase NA Completed
130 enrolled
BreastGastrointestinalGynecologic

Breast Neoplasms, Colorectal Neoplasms, Hereditary Nonpolyposis, Ovarian Neoplasms, Hereditary Breast and Ovarian Cancer Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡